The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Rash On Legs vs Wegovy — What You Need to Know
Rashes and skin reactions can occur with both Mounjaro (tirzepatide) and Wegovy (semaglutide), though they're not among the most common side effects reported in clinical trials. Both medications are once-weekly injections for weight management in the UK, but they work differently and may affect individuals differently. Understanding the difference between these GLP-1 and dual GIP/GLP-1 medications can help you discuss options with your prescriber during a clinical assessment.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro and Wegovy Compare for Skin Side Effects
Injection site reactions are more commonly reported than generalised rashes with both medications. In clinical trials, injection site redness, bruising, and pain occurred in some participants but were usually mild and temporary.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist. Clinical trial data from SURMOUNT-1 showed injection site reactions in a small percentage of participants, though specific rash incidence on legs was not separately reported.
Wegovy (semaglutide) is a GLP-1 agonist only. STEP trial data similarly showed injection site reactions but no significant pattern of leg rashes. Both medications use the upper thigh as one approved injection site, which may cause localised reactions if the same site is used repeatedly without rotation.
Individual responses vary significantly. Some people experience no skin reactions at all, whilst others may develop mild irritation. If you rotate injection sites between stomach, thigh, and upper arm as recommended, localised reactions are less likely.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
When to Seek Help and How Your Prescriber Can Help
If you develop a rash on your legs or at injection sites, contact your GP or prescriber immediately if the rash is spreading, painful, blistering, or accompanied by fever or swelling. Most localised reactions settle within a few days with simple care — keeping the area clean and avoiding tight clothing.
Your prescriber may suggest changing injection technique, rotating sites more frequently, or investigating whether the reaction is related to the medication itself or a skin irritant like an antiseptic wipe or adhesive tape.
Neither Mounjaro nor Wegovy is right for everyone. A licensed prescriber will assess your individual health history, current medications, and any previous skin conditions before prescribing. Both require a UK clinical assessment and are prescription-only. If you're considering either medication, use our free GLP-1 weight loss calculator to explore potential weight loss outcomes, and discuss eligibility with your GP or a licensed prescriber.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can Mounjaro cause a rash on legs?
Injection site reactions including redness and mild irritation can occur with Mounjaro, especially if you repeatedly inject in the same spot. A generalised rash on legs unrelated to injection sites is not a commonly reported side effect in clinical trials, but any new rash should be reported to your prescriber.
Is a rash more likely with Mounjaro or Wegovy?
Clinical trial data (SURMOUNT for Mounjaro, STEP for Wegovy) do not show a significant difference in rash incidence between the two medications. Both can cause injection site reactions. Individual responses vary greatly, and pre-existing skin conditions may affect likelihood.
What should I do if I develop a rash after starting a GLP-1 injection?
Contact your GP or prescriber. If the rash is mild and only at the injection site, rotate to a different injection site next week. If the rash spreads, blisters, or is accompanied by swelling or fever, seek medical advice promptly.
Why does Mounjaro work differently from Wegovy?
Mounjaro is a dual GIP and GLP-1 receptor agonist, whilst Wegovy is a GLP-1 agonist only. This means Mounjaro activates two hormone pathways to regulate appetite. In clinical trials, this dual action resulted in slightly higher average weight loss, though individual results vary significantly.
How do I know which weight loss injection is right for me?
Only a licensed UK prescriber can assess your eligibility following a clinical assessment. Both Mounjaro and Wegovy require a prescription and are suitable only for adults with a BMI of 30 or above, or 27 or above with weight-related health conditions. Discuss your medical history, skin conditions, and preferences with your prescriber.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.